Get the Stockscreener App
1.97
0.51%
0.01
Pre-market:
2.01
0.04
+2.03%
Cardio Diagnostics Holdings Inc stock is traded at $1.97, with a volume of 38,632.
It is up +0.51% in the last 24 hours and up +27.10% over the past month.
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.
See More
Previous Close:
$1.96
Open:
$1.97
24h Volume:
38,632
Relative Volume:
0.30
Market Cap:
$5.83M
Revenue:
$16,600
Net Income/Loss:
$-6.65M
P/E Ratio:
-0.5837
EPS:
-3.3752
Net Cash Flow:
$-6.32M
1W Performance:
-1.01%
1M Performance:
+27.10%
6M Performance:
-36.04%
1Y Performance:
-51.48%
1-Day Range:
$1.94
$2.085
1-Week Range:
$1.8648
$2.11
52-Week Range:
$0.97
$7.91
Cardio Diagnostics Holdings Inc Stock (CDIO) Company Profile
Name
Cardio Diagnostics Holdings Inc
Sector
Industry
Phone
855-226-9991
Address
311 W. SUPERIOR STREET, CHICAGO
Compare CDIO vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDIO
Cardio Diagnostics Holdings Inc
|
1.97 | 5.83M | 16,600 | -6.65M | -6.32M | -3.3752 |
VRTX
Vertex Pharmaceuticals Inc
|
450.46 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
614.98 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
884.20 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
287.80 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
160.06 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cardio Diagnostics Holdings Inc Stock (CDIO) Latest News
Cardio Diagnostics (CDIO) Harnesses AI, Genetics and Epigenetics to Advance Cardiovascular Risk Detection - NewMediaWire
Cardio Diagnostics (NASDAQ: CDIO) Harnesses AI, Genetics and Epigenetics to Advance Cardiovascular Risk Detection - TipRanks
Cardio Diagnostics Holdings (CDIO) Slips 2% as Shares Test Key Support Near $1.86Fibonacci Entry Signals - newsline.com
Cardio Diagnostics Uses AI and Genetics to Improve Cardiovascular Risk Detection - citybuzz -
CDIO Should I Buy - Intellectia AI
CDIO Q1 2025 Earnings: Narrower-Than-Expected Loss Lifts SharesQuarterly Profit Report - newsline.com
CDIO Q1 2025 Earnings: EPS Surprises to the Upside Despite No RevenueDebt Analysis Report - newsline.com
Cardio Diagnostics Stock Jumps as Tiny Heart-Test Firm Heads Into June Benefits Push - Bez Kabli
CDIO Q1 2025 Earnings: EPS Surpasses Estimates on Narrower Loss, Stock RisesGuidance Revision Trend - The Legal Advocate
CDIO Q1 2025 Earnings: EPS Surprise Beats Estimates by 47%, but Stock DeclinesEPS Guidance Update - newsline.com
CDIO Q1 2025 Earnings: EPS Surprise of 47% Highlights Improved Cost ManagementDividend Earnings Report - The Legal Advocate
CDIO Q1 2025 Earnings: Loss Narrows, Beats Estimates Amid Pre-Revenue StageMargin Improvement Report - The Legal Advocate
Cardio Diagnostics to Showcase AI-Powered Heart Risk Tools at Four Benefits Conferences - MEXC
Cardio Diagnostics Holdings Warrant (CDIOW) Stays at Penny Level Amid Minimal Price ChangePrice Surge Stocks - thelegaladvocate.com
Cardio Diagnostics to Present AI Cardiovascular Risk Tools at Benefits Conferences - MEXC
Cardio Diagnostics to showcase cardiovascular solutions at four conferences - TipRanks
Cardio Diagnostics Holdings (CDIO) Showcases AI-Powered Cardiovascular Risk Solutions at Four National Benefits Conferences - Yahoo Finance
Cardio Diagnostics Holdings (NASDAQ: CDIO) Showcases AI-Powered Cardiovascular Risk Solutions at Four National Benefits Conferences - TradingView
Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June 2026 - BioSpace
Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June - The Joplin Globe
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
CDIO Q1 2025 Earnings: Narrowed Loss Beats Estimates SignificantlyBasic EPS Analysis - The Legal Advocate
Cardio Diagnostics Holdings (CDIO) Surges 6.62% as Shares Test Resistance Near $1.69Professional Trade Ideas - Newser
CDIO Q1 2025 Earnings: Narrower-than-expected loss surprises marketDebt Analysis Report - Newser
Cardio Diagnostics Hldgs Analyst Ratings and Price Targets | NASDAQ:CDIO - Benzinga
What's Driving Cardio Diagnostics Holdings' Recent Stock Surge - Kavout
Cardio Diagnostics CEO Discusses Growth Strategy and India Expansion on BioMedWire Podcast - citybuzz -
Cardio Diagnostics Holdings (CDIO) CEO Highlights Growth Strategy, India Expansion on BioMedWire Podcast - Yahoo Finance
Cardio Diagnostics Holdings (NASDAQ: CDIO) CEO Highlights Growth Strategy, India Expansion on BioMedWire Podcast - Barchart.com
IBN Announces Latest Episode of The BioMedWire Podcast - GlobeNewswire
Cardio Diagnostics Holdings (CDIO) Focused on Vision for Personalized Heart Care - Yahoo! Finance Canada
Cardio Diagnostics Holdings (CDIO) Offers Broad Suite of AI-Powered Solutions for Cardiovascular Disease Prevention - Yahoo Finance
Cardio Diagnostics Holdings (NASDAQ: CDIO) Focused on Vision for Personalized Heart Care - TradingView
Cardio Diagnostics Aims to Transform Heart Care with AI-Driven Personalized Medicine - citybuzz -
Cardio Diagnostics Holdings (NASDAQ: CDIO) Offers Broad Suite of AI-Powered Solutions for Cardiovascular Disease Prevention - TradingView
Cardio Diagnostics Leverages AI to Address Preventable Cardiovascular Disease - citybuzz -
Cardio Diagnostics Holdings, Inc. 1Q 2026: Revenue $2.68K, EPS ($0.63) — 10-Q Summary - TradingView
Cardio Diagnostics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Cardio Diagnostics (NASDAQ: CDIO) posts Q1 2026 loss, boosts cash via stock sales - Stock Titan
Cardio Diagnostics Poised at Intersection of Precision Medicine and Preventive Care as Cardiovascular Disease Burden Grows - citybuzz -
TradingKey - TradingKey
Number of shareholders of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIO - TradingView
The real value proposition of Cardio Diagn (CDIO) stock (-1.64%) 2026-05-11Earnings Season - newser.com
CDIO Price Today: Cardio Diagnostics Holdings Inc. Stock Price, Quote & Chart | MEXC - MEXC
What XXxs fundamentals reveal about its future (Investors Pile In) 2026-05-08Aggressive Growth Stocks - newser.com
Cardio Diagnostics Holdings Inc Stock (CDIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.40%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):